Cargando…
Pathogenic Role of microRNA-21 in Diabetic Retinopathy Through Downregulation of PPARα
Fenofibrate, a specific agonist of peroxisome proliferator–activated receptor-α (PPARα), displays robust therapeutic effects on diabetic retinopathy (DR) in patients with type 2 diabetes. Our recent studies have shown that PPARα is downregulated in the diabetic retina, which contributes to the patho...
Autores principales: | Chen, Qian, Qiu, Fangfang, Zhou, Kelu, Matlock, H. Greg, Takahashi, Yusuke, Rajala, Raju V.S., Yang, Yanhui, Moran, Elizabeth, Ma, Jian-xing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440012/ https://www.ncbi.nlm.nih.gov/pubmed/28270521 http://dx.doi.org/10.2337/db16-1246 |
Ejemplares similares
-
Pathogenic Role of PPARα Downregulation in Corneal Nerve Degeneration and Impaired Corneal Sensitivity in Diabetes
por: Matlock, H. Greg, et al.
Publicado: (2020) -
Therapeutic Effects of PPARα Agonists on Diabetic Retinopathy in Type 1 Diabetes Models
por: Chen, Ying, et al.
Publicado: (2013) -
Interaction of PPARα With the Canonic Wnt Pathway in the Regulation of Renal Fibrosis
por: Cheng, Rui, et al.
Publicado: (2016) -
Therapeutic Potential of a Monoclonal Antibody Blocking the Wnt Pathway in Diabetic Retinopathy
por: Lee, Kyungwon, et al.
Publicado: (2012) -
New Diabetes Diagnostic Threshold of Hemoglobin A(1c) and the 3-Year Incidence of Retinopathy
por: Tsugawa, Yusuke, et al.
Publicado: (2012)